StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30105% above fair value
$14.35+0.14 (+0.99%)

Close on Nov 18, 2026Market cap $38.31MP/E –Yield –

Earnings

Yarrow Bioscience's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2026
–
Adjusted EPS, Q3 FY2026
-$0.43
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Yarrow Bioscience's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Nov 12, 2026before the open––-$0.43–Release
Q2 FY2026ended Jun 30, 2026Jul 28, 2026after the close––––Release
Q2 FY2025ended Jun 30, 2025Jul 30, 2025before the open––––Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open$200.00K+100.0%-$0.20–Release
Q4 FY2024ended Dec 31, 2024Mar 6, 2025before the open$84.00K+10.5%-$0.28–Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$100.00K0.0%-$0.29–Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024before the open$200.00K+100.0%-$0.22–Release
Q1 FY2024ended Mar 31, 2024May 9, 2024before the open$100.00K0.0%-$0.15–Release
Q4 FY2023ended Dec 31, 2023Feb 29, 2024before the open$76.00K+1166.7%-$0.20-$0.18Release
Q3 FY2023ended Sep 30, 2023Nov 13, 2023before the open$100.00K-50.0%-$2.01-$1.75Release
Q2 FY2023ended Jun 30, 2023Aug 14, 2023before the open$100.00K0.0%-$3.09-$2.82Release
Q1 FY2023ended Mar 31, 2023May 11, 2023after the close$100.00K-50.0%-$1.74-$1.48Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Yarrow Bioscience has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Yarrow Bioscience puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Yarrow Bioscience filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Update
  10. Update
  11. Update
  12. Update
  13. Update
  14. Update
  15. Results

See a number that looks wrong?